Table 2.

Summary of three clinical vignettes exemplifying real-world cases of patients with DS and immunodeficiency, autoimmunity, and autoinflammation, respectively

Patient ageOther past medical historyPresenting issueLaboratory and clinical findingsDiagnosisRecommended treatment
Case #1
6-year-old male with DS 
Congenital heart disease Recurrent infections (otitis media, croup, pneumonia, pharyngeal abscess, folliculitis, and conjunctivitis) Mild hypogammaglobulinemia (IgM 18 mg/dl; IgG 499 mg/dl; IgA 42 mg/dl; IgE 3 mg/dl); CD19 and CD8 lymphopenia; reduced class-switched memory B cells; absent pneumococcal, measles, mumps, rubella, varicella, and hepatitis B titers despite boosters; preserved tetanus and diphtheria titers Specific antibody deficiency Immunoglobulin replacement therapy 
Case #2
25-year-old male with DS 
N/A Poor oral intake and dysphagia; anorexia and 50-lb unintentional weight loss; gait instability, cognitive slowing, social withdrawal, and fatigue Imaging consistent with sialadenitis; autoimmune hypothyroidism and primary adrenal insufficiency; brain MRI showing mild ventriculomegaly, cerebellar hypoplasia, and basal-ganglia mineralization; normal Alzheimer’s biomarkers and vitamin B12 DSRD Levothyroxine and corticosteroids; considering benzodiazepines, immunoglobulin, and JAK inhibition 
Case #3
16-year-old female with DS 
Hypothyroidism, obstructive sleep apnea, eruptive syringomas, seborrheic dermatitis, papular eczema, and alopecia areata Progressive, treatment-refractory hidradenitis suppurativa with painful axillary abscesses requiring hospitalization Persistent severe hidradenitis suppurativa flares despite adalimumab therapy, prolonged doxycycline, and multiple intralesional triamcinolone injections; required intravenous antibiotics and high-dose corticosteroids Hidradenitis suppurativa in the context of DS-associated cutaneous inflammation Transition from adalimumab to secukinumab 
Patient ageOther past medical historyPresenting issueLaboratory and clinical findingsDiagnosisRecommended treatment
Case #1
6-year-old male with DS 
Congenital heart disease Recurrent infections (otitis media, croup, pneumonia, pharyngeal abscess, folliculitis, and conjunctivitis) Mild hypogammaglobulinemia (IgM 18 mg/dl; IgG 499 mg/dl; IgA 42 mg/dl; IgE 3 mg/dl); CD19 and CD8 lymphopenia; reduced class-switched memory B cells; absent pneumococcal, measles, mumps, rubella, varicella, and hepatitis B titers despite boosters; preserved tetanus and diphtheria titers Specific antibody deficiency Immunoglobulin replacement therapy 
Case #2
25-year-old male with DS 
N/A Poor oral intake and dysphagia; anorexia and 50-lb unintentional weight loss; gait instability, cognitive slowing, social withdrawal, and fatigue Imaging consistent with sialadenitis; autoimmune hypothyroidism and primary adrenal insufficiency; brain MRI showing mild ventriculomegaly, cerebellar hypoplasia, and basal-ganglia mineralization; normal Alzheimer’s biomarkers and vitamin B12 DSRD Levothyroxine and corticosteroids; considering benzodiazepines, immunoglobulin, and JAK inhibition 
Case #3
16-year-old female with DS 
Hypothyroidism, obstructive sleep apnea, eruptive syringomas, seborrheic dermatitis, papular eczema, and alopecia areata Progressive, treatment-refractory hidradenitis suppurativa with painful axillary abscesses requiring hospitalization Persistent severe hidradenitis suppurativa flares despite adalimumab therapy, prolonged doxycycline, and multiple intralesional triamcinolone injections; required intravenous antibiotics and high-dose corticosteroids Hidradenitis suppurativa in the context of DS-associated cutaneous inflammation Transition from adalimumab to secukinumab 

or Create an Account

Close Modal
Close Modal